Xiaohui Lu
Dr. Xiaohui Lu is an Executive Director of Analytical Development at Ultragenyx, heading the analytical effort for the company’s gene therapy programs for the past 4 years. Prior to joining Ultragenyx, Dr. Lu held various positions at CRISPR Therapeutics, Biogen, and Ariad Pharmaceuticals. Dr. Lu received his Ph.D. in Biochemistry from Dartmouth Medical School and had post-doctoral training at the Whitehead Institute.
Appearances
DateJune 27, 2023Potency testing is a critical part of the assessment and release of cell therapy products. These functional assays provide quantitative assessments of the biological activity of a cell or gene therapy product that are associated with that product’s in vivo mechanism(s) of action (MOA)…Session Chairs
